Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NMB vs Placebo in Hip Fracture Repair
NCT03226080Phase 4Withdrawn
- Sponsor
- Loyola University Chicago
- Start
- Jul 2017
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rocuronium in hip fracture, sponsored by Loyola University Chicago. Planned start Jul 2017; status: withdrawn.
02
Drugs
rocuronium
03
Conditions
hip fracture
Beyond the preview
Go deeper on NCT03226080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03226080.